INS and type 2 diabetes mellitus: Knockout of UCP2 in pancreatic β-cells enhances glucose-induced insulin secretion (Robson-Doucette et al., 2011), while its overexpression inhibits this process, increasing the risk of type 2 diabetes in humans (Chan et al., 1999).